Browse > Article
http://dx.doi.org/10.5392/JKCA.2017.17.11.050

Evaluation of the Liver Cancer Diagnosis Function of PET-MRI Based on Decision Matrix Analysis  

Kim, Jin-Eui (동신대학교 방사선학과)
Kim, Jung-Soo (동남보건대학교 방사선과)
Choi, Nam-Gil (동신대학교 방사선학과)
Han, Jae-Bok (동신대학교 방사선학과)
Publication Information
The Journal of the Korea Contents Association / v.17, no.11, 2017 , pp. 50-59 More about this Journal
Abstract
To evaluate the capability of integrated PET-MRI, which has recently been utilized in the clinical practices, on the diagnosis of liver cancer, its utility was assessed by $2{\times}2$ decision matrix. The numbers of abnormal and normal decisions on the liver cancer were 98 and 51 cases, respectively, upon PET-MRI scan results of the subjects, and the numbers of positive and negative decisions were 103 and 62, respectively, upon cytopathologic results. Out of the two tests, 95 cases were shown as true-positive and 3 were false positive, while 62 were true negative and 5 were false negative. Upon the results of PET-MRI test, its sensitivity, specificity, false negative rate, and false positive rate were 95.00%, 95.38%, 0.05%, and 95.15%, respectively. Therefore, it is considered to have the high potential to use the determination of the stage before the surgery, detections of recurrence and remote metastasis, assessment of uncertain remote lymph node metastasis, and so on in the diagnosis of the liver cancer, and also for the clinical utility of PET-MRI to be sufficient by integrated diagnosis and follow up scan with pathological studies.
Keywords
Decision Matrix; PET-MRI; Liver Cancer; Diagnosis Function;
Citations & Related Records
연도 인용수 순위
  • Reference
1 K. W. Jung, Y. J. Won, C. M. Oh, H. J. Kong, D. H. Lee, and K. H. Lee, "Cancer statistics in korea: incidence, mortality, survival, and prevalence in 2014," Cancer research and Treatment, Vol.49, No.2, pp.292-305, 2017.   DOI
2 Ran Xu Zhu, Wai-Kay Seto, Ching-Lung Lai, Man-Fung Yuen, M. J. Daly, and R. E. Henly, "Epidemiology of hepatocellular carcinoma in the asia-pacific region," Gut Liver, Vol.10, No.3, pp.332-339, 2016.
3 S. K. Yoon and H. G. Chun, "Status of hepatocellular carcinoma in south korea," Chin Clin Oncol, Vol.2, No.4, p.39, 2013.
4 E. Y. Lee, T. T. Xuan Mai, Y. J. Chang, and M. R. Ki, "Trends of liver cancer and its major risk factors in korea," Epidemiol Health, Vol.37, p.e2015016, 2015.   DOI
5 Robert G. Gish, Richard S. Finn, and Jorge A. Marrero, "Extending survival with the use of targeted therapy in the treatment of hepatocellular carcinoma," Gastroenterol Hepatol, Vol.9, No.4, suppl.2, pp.1-24, 2013.
6 Josep M. Llovet, Maria Isabel Real, Xavier Montana, Ramon Planas, Susana Coll, John Aponte, Carmen Ayuso, Margarita Sala, Jordi Muchart, Ricard Sola, Joan Rodes, and Jordi Bruix, "Arterial embolisation or chemoembolisation versus symptomatic," Lancet, Vol.359, pp.1734-1739, 2002.   DOI
7 Gerald D. Dodd, Michael C. Soulen, Robert A. Kane, Tito Livraghi, William R. Lees, Yasuyuki Yamashita, Alison R. Gillams, Okkes I. Karahan, and H. C. Rhim, "Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough," Radiographics, Vol.20, pp.9-27, 2000.   DOI
8 D. G. Farmer, M. H. Rosove, A. Shaked, and R W. Busuttil, "Current treatment modalities for hepatocellular carcinoma," Ann Surg, Vol.219, pp.236-247, 1994.   DOI
9 F. F. Haddad, W. C. Chapman, J. K. Wright, T. K. Blair, and C. W. Pinson, "Clinical experience with cryosurgery for advanced hepatobiliary tumors," J Surg Res., Vol.75, pp.103-108, 1998.   DOI
10 Eric C. Ehman, Geoffrey B. Johnson, Javier E. Villanueva-Meyer, S. M. Cha, Andrew Palmera Leynes, Peder Eric Zufall Larson, and Thomas A. Hope, "PET/MRI: Where might it replace PET/CT?," J Magn Reson Imaging, doi:10.1002/jmri.25711, 2017.   DOI
11 Felix Nensa, Karsten Beiderwellen, Philipp Heusch, and Axel Wetter, "Clinical applications of PET/MRI: current status and future perspectives," Diagn Interv Radiol, Vol.20, No.5, pp.438-447, 2014.   DOI
12 W. Atkinson, C. Catana, J. S. Abramson, G. Arabasz, S. McDermott, O. Catalano, V. Muse, M. A. Blake, J. Barnes, M. Shelly, E. Hochberg, B. R. Rosen, and A. R. Guimaraes, "Hybrid FDG-PET/MR compared to FDG-PET/CT in adult lymphoma patients," Abdom Radiol, Vol.41, pp.1338-4138, 2016.   DOI
13 K. Beiderwellen, M. Huebner, P. Heusch, J. Grueneisen, V. Ruhlmann, F. Nensa, H. Kuehl, L. Umutlu, S. Rosenbaum-Krumme, and T. C. Lauenstein, "Whole-body [$^{18}F$]FDG PET/MRI vs. PET/CT in the assessment of bone lesions in oncological patients: initial results," Eur Radiol., Vol.24, No.8, pp.2023-2030, 2014.   DOI
14 C. M. Tempany, J. Jayender, T. Kapur, T. Kapur, R. Bueno, A. Golby, N. Agar, and F. A. Jolesz, "Multimodal imaging for improved diagnosis and treatment of cancers," Cancer, Vol.121, pp.817-827, 2015.   DOI
15 Toshio Wagai, "Studies on the foundation and development of diagnostic ultrasound," Proc Jpn Acad Ser B Phys Biol Sci., Vol.83, No.8, pp.256-265, 2007.   DOI
16 A. Samarin, M. Hullner, M. A. Queiroz, P. Stolzmann, I. A. Burger, G. Von Schulthess, and P. Veit Haibach, "$^{18}F$-FDG-PET/MR increases diagnostic confidence in detection of bone metastases compared with $^{18}F$-FDG-PET/CT," Nucl Med Commun., Vol.36, No.12, pp.1165-1173, 2015.   DOI
17 Kathy Schilling, Deepa Narayanan, Judith E. Kalinyak, Juliette The, Maria Victoria Velasquez, Simone Kahn, Matthew Saady, Ravinder Mahal, and Larraine Chrystal, "Positron emission mammography in breast cancer presurgical planning: comparisons with magnetic resonance imaging," Eur J Nucl Med Mol Imaging, Vol.38, No.1, pp.23-36, 2011.   DOI
18 K. Beiderwellen, L. Geraldo, V. Ruhlmann, P. Heusch, B. Gomez, F. Nensa, L. Umutlu, and T. C. Lauenstein, "Accuracy of [$^{18}F$]FDG PET/MRI for the detection of liver metastases," PLoS ONE, Vol.10, No.9, p.e0137285, 2015.   DOI
19 Philipp Heusch, Felix Nensa, Benedikt Schaarschmidt, Rupika Sivanesapillai, Karsten Beiderwellen, Benedikt Gomez, Jens Kohler, Henning Reis, Verena Ruhlmann, and Christian Buchbender, "Diagnostic accuracy of whole-body PET/MRI and whole-body PET/CT for TNM staging in oncolog," Eur J Nucl Med Mol Imaging, Vol.42, No.1, pp.42-48, 2015.   DOI
20 Ali Civelek, Anshuma Rana, Ashkan Malayeri, Justin Rodante, Amit Dey, Nehal Mehta, and David Bluemke, "PET-MRI derived 18F-FDG liver SUV metrics: effects of hepatic steatosis and comparison with PET-CT," J Nucl Med., Vol.58, No.1, p.455, 2017.
21 Ahmet Mert, Niyazi Kilic, Erdem Bilgili, and Aydin Akan, "Breast cancer detection with reduced feature set," Comput Math Methods Med., doi:10.1155/2015/265138, 2015.   DOI
22 A. Marcano-Cedeno, Paloma Chausa, Alejandro Garcia, Cesar Caceres, Josep M. Tormos, and Enrique J. Gomez, "Data mining applied to the cognitive rehabilitation of patients with acquired brain injury," Exp Sys Appl., Vol.40, No.4, pp.1054-1060, 2013.   DOI
23 Dushyant V. Sahani and Sanjeeva P. Kalva, "Imaging the liver," The Oncologist, Vol.9, No.4, pp.385-397, 2004.   DOI
24 Claudio Spick, Ken Herrmann, and Johannes Czernin, "$^{18}F$-FDG PET/CT and PET/MRI perform equally well in cancer: evidence from studies on more than 2,300 Patients," J Nucl Med, Vol.57, No.3, pp.420-430, 2016.   DOI
25 Bing Bai, Quanzheng Li, and Richard M. Leahy, "MR guided PET image reconstruction," Semin Nucl Med., Vol.43, No.1, pp.30-44, 2014.   DOI
26 Ahmedin Jemal, Freddie Bray, Melissa M. Jacques Ferlay, Elizabeth Ward, and David Forman, "Global cancer statistics," Ca cancer J Clin., Vol.61, pp.69-90, 2011.   DOI
27 Ruben Hernaez, Mariana Lazo, Susanne Bonekamp, Ihab Kamel, Frederick L. Brancati, Eliseo Guallar, and Jeanne M. Clark, "Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis," Hepatology, Vol.54, No.3, pp.1082-1090, 2011.   DOI
28 Eldad S. bialecki and Adrian M. Di Bisceglie, "Diagnosis of hepatocellular carcinoma," HPB(Oxford), Vol.7, No.1, pp.26-34, 2005.   DOI
29 A. Abbasi, A. R. Bhutto, N. Butt, and S. M. Munir, "Corelation of serum alpha fetoprotein and tumor size in hepatocellular carcinoma," J Pak Med Assoc, Vol.62, No.1, pp.33-36, 2012.
30 Marialuigina Fruscella, Antonio Ponzetto, Annalisa Crema, and Guido Carloni, "The extraordinary progress in very early cancer diagnosis and personalized therapy: the role of oncomarkers and nanotechnology," J Nanotech, doi:10.1155/2016/3020361, 2016.   DOI
31 Andrew J. Vickers, "Decision analysis for the evaluation of diagnostic tests, prediction models and molecular markers," Am Stat., Vol.62, No.4, pp.314-320, 2008.   DOI
32 Peter R. Killeen, "Beyond statistical inference: A decision theory for science," Psychon Bull Rev., Vol.13, No.4, pp.549-562, 2006.   DOI